cerus.com (CERS): Operating Profitability

Cerus Corporation (CERS) - corporate logo

Cerus Corporation (CERS) relies on competent management and the transparent revenue system of Intercept. Business development is based on the implementation of blood purification technologies in medical centers. Financial stability is supported by government procurement of anti-viral systems. Meanwhile, the value of -12.20 reflects the metric balance, which is clearly demonstrated by the actual operating margin.

CERS - Cerus Operating Profit Ratio over the range 07/04/2022 - 11/20/2026

Analytical breakdowns for Cerus Corporation

- share price and consensus valuation forecast:
- stock exchange capitalization data:
Fundamental company analysis:CERS, Cerus Corp
Finished products of Cerus Inc

Minimizing fundamental risks requires selecting assets with a sustainable ability to generate cash flow. This metric reflects the share of operating profit in total revenue, excluding the impact of debt load and the tax regime. For Cerus Corporation (CERS), this is an indicator of the scaling efficiency of INTERCEPT systems within the hospital sector. Analyzing the operating margin before taxes and interest allows for an assessment of the real profitability of key technologies. The operating margin trend before taxes and interest reveals the business's adaptability to market stresses.

Competitor analysis for Cerus Corporation

ISRG (intuitive.com) - Operating Margin|Return on Sales by Operating Profit DHR (Danaher Corp.)|Operating Sales Margin BDX (Becton, Dickinson and Company)|Operating Profit Ratio STE|Operating Profitability West Pharma WST|Profitability of Operations Baxter (BAX)|MASI - Operating Profitability|Profitability of Operations Stevanato Group Corp STVN|TFX: Operating Margin|Operating Sales Margin Merit Medical Systems|Operating Profitability Envista Holdings Corp|Operating Sales Margin ICU Medical Corp (ICUI)|Operating Profitability DENTSPLY SIRONA Inc. (XRAY)|Operating Sales Margin LeMaitre LMAT|Operating Margin ATRC (atricure.com)|Operating Margin staar.com STAA|NAGE - Operating Profitability|Profitability of Operations ZimVie ZIMV|ANGO: Operating Margin|Alpha Teknova, Inc. - Operating Profit Rate|MGRM (Monogram Orthopedics Inc.) - Operating Margin|STSS: Operating Profit Rate|Operating Sales Margin INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Return on Sales by Operating Profit|Operating Margin KRMD (korumedical.com)|Profitability of Operations Nyxoah, S.A. (NYXH)|MBOT - Operating Profitability|PDEX (Pro-Dex, Inc.) - Return on Sales by Operating Profit|ZTEK (Zentek Ltd) - Operating Sales Margin|ELUT - Profitability of Operations|MLSS (Milestone Scientific Corporation) - Operating Margin|Return on Sales by Operating Profit NXGL (NEXGEL, Inc.)|Operating Margin RVP|Operating Sales Margin Harvard Bioscience HBIO|Operating Margin FEMY (Femasys Corporation)|MHUA - Operating Sales Margin|POAI - Operating Profitability|Callan JMB (CJMB) - Operating Sales Margin|ATRI: Operating Margin|NURO - Profitability of Operations